← Open Payments lookup

RENEE RHEM: Open Payments

NPI 1346509239 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,330 in 130 payments from 18 companies in 2025. Trend: 2023 $2,566 · 2024 $2,580 · 2025 $4,330

Food & beverage: $4,235Education: $95
CompanyPaymentsAmount
GENZYME CORPORATION19$934
AstraZeneca Pharmaceuticals LP14$661
CSL Behring23$635
GlaxoSmithKline, LLC.20$481
Galderma Laboratories, L.P.10$294
ARS Pharmaceuticals Operations, Inc.7$237
Novartis Pharmaceuticals Corporation6$227
Ionis Pharmaceuticals, Inc.12$139
Organon LLC2$137
ConvaTec Inc.1$135

Products named: DUPIXENT, TEZSPIRE, Haegarda, NEMLUVIO, Andembry, NUCALA, NEFFY, FASENRA.

Industry payments across NY — which companies pay providers there.